// App-Quantinova.ai

: STEM-21. INVESTIGATING DOT1L AS AN EPIGENETIC VULNERABILITY IN BRAIN TUMOR STEM CELLS

Researchers

Presenter

  • Danielle Bozek

Principal Investigators

  • Graham MacLeod

  • Xiaoguang Hao

  • Nishani Rajakulendran

  • Moloud Ahmadi

  • Peter Dirks

  • Stephane Angers

  • Artee Luchman

  • Sam Weiss

Medical Centers

  • Hotchkiss Brain Institute, Department of Cell Biology and Anatomy, Cumming School of Medicine, Calgary, AB, Canada

  • University of Toronto, Leslie Dan Faculty of Pharmacy, Toronto, ON, Canada

  • University of Calgary, Calgary, AB, Canada

  • Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain cancer

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pinometostat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved